LCM
XENE icon

Laurion Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Laurion Capital Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-171,195
Closed -$6.67M – 620
2024
Q2 		$6.67M Sell
171,195
-67,931
-28% -$2.72M 0.08% 137
2024
Q1 		$10.3M Buy
239,126
+164,126
+219% +$7.55M 0.09% 188
2023
Q4 		$3.45M Buy
+75,000
New +$2.65M 0.03% 262
2022
Q3 		– Sell
-10,000
Closed -$304K – 618
2022
Q2 		$304K Buy
+10,000
New +$302K ﹤0.01% 369

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Laurion Capital Management's XENE Position: Q3 2024 in Review

Laurion Capital Management sold out of Xenon Pharmaceuticals (XENE) in Q3 2024, closing a stake of 171,195 shares — an estimated $6.67M sold.

Laurion Capital Management first reported a position in XENE in Q2 2022 and held it in 4 quarters. The position peaked at $10.3M in Q1 2024. 203 funds tracked by Wall St. Rank hold XENE as of Q3 2024.

  • Laurion Capital Management reported no remaining Xenon Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 171,195 Xenon Pharmaceuticals shares in Q3 2024, an estimated $6.67M.
  • Laurion Capital Management first reported a position in Xenon Pharmaceuticals in Q2 2022 and held it in 4 quarters.
  • Laurion Capital Management's Xenon Pharmaceuticals position peaked at $10.3M in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.